Arrhythmogenic cardiomyopathy (AC) is a rare inherited heart muscle condition that causes irregular heart rhythms (arrhythmias) at a higher rate than other heart muscle conditions. AC can affect primarily either the left ventricle (Left Dominant Arrhythmogenic Cardiomyopathy) or the right ventricle (Arrhythmogenic Right Ventricular Cardiomyopathy or ARVC). Individuals with AC or ARVC may have symptoms of palpitations or fainting due to arrhythmias. Symptoms may also include shortness of breath due to reduced pumping function of the heart.
Medical Services related to Richard George Ohye MD
At the Congenital Heart Center at C.S. Mott Children's Hospital, our goal is to provide the best possible care for infants, children and adolescents with all forms of congenital and acquired heart disease, as well as adults with congenital heart disease.
Dilated cardiomyopathy, or DCM, is a heart muscle condition characterized by gradual weakening of the heart muscle. While DCM may be caused by other conditions, including myocardial infarction, many cases are now known to be caused by genetic mutations carried in families. Individuals with DCM may be only mildly affected or may be severely affected, even in the same family.
The University of Michigan offers the state's only accredited heart failure disease management program, with medical and surgical care, heart-assisting technology and comprehensive rehabilitation programs.
Heart failure in children is often caused by a congenital heart defect the child is born with, heart failure due to genetic defects, heart muscle abnormalities (cardiomyopathy), infection, arrhythmia, hypertension, valve disease or other medical conditions. C.S. Mott Children’s Hospital is one of the nation’s top children’s heart programs, and the Michigan Medicine Transplant Center is the largest and most experienced transplant center in Michigan.
Heart transplant is one of a number of options for severe heart disease. It's not for everyone, and should not be considered unless all other viable treatment options have been unsuccessful. At the University of Michigan Heart Transplant Program, our closely integrated team of cardiac transplant surgeons and transplant cardiologists are able to treat and implant donor hearts in the sickest of patients because of our high volume, vast experience and active research program.
A heart transplant improves the length and quality of life of children whose own hearts have failed. At the University of Michigan Pediatric Heart Transplant Program, our dedicated, multidisciplinary team of pediatric cardiac transplant surgeons and transplant cardiologists provides coordinated and comprehensive evaluation, treatment and follow-up for children from newborn to 18 years old and our active research program means our patients have access to the newest treatments available.
Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disorder affecting 1 in 500 people. It affects both men and women of all ages, and is characterized by abnormal thickening of the heart muscle.
Pulmonary atresia (PA) is a rare congenital abnormality of heart development where the pulmonary valve that controls blood flow from the right side of the heart to the lungs doesn’t form (atresia).
C.S. Mott Children’s Hospital transplant nurses, transplant coordinators, social workers and all our team members are committed to helping your family understand as much as possible about the transplant process. We are here for you and happy to answer any questions along the way.
A ventricular assist device (VAD) is a mechanical pump that is placed into a poorly functioning heart to improve the circulation of blood through the body. A VAD is put in to help organs get better and to improve heart failure symptoms. The Congenital Heart Center at C.S. Mott Children’s Hospital is a destination for children and families with complex heart disease, with special expertise in the use of VADs for children with heart failure.